UnitedHealth Group's strong 2018 performance, with record sales and earnings growth, along with confident forward guidance for 2019, suggests a positive outlook despite Medicaid cost pressures. The company's diversified revenue streams, focus on cost management, and innovation efforts indicate resilience and potential for a slight rally in the stock price in the near term. However, the concerns about Medicaid margins could temper the rally.
[1]